HHealthcare Read More This medical device stock looks like a gift for patient investorsSeptember 1, 2026 Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
HHealthcare Read More AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?August 11, 2026 Choosing between a high-yield pharmaceutical powerhouse and a diversified healthcare leader requires looking at growth and stability. You…
AArtificial intelligence Read More Meta’s latest move in the AI talent war, plus Cramer’s 4 quick hitsJuly 17, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
AArtificial intelligence Read More Apple’s China breakthrough provides another tailwind for its stockJuly 15, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
AArtificial intelligence Read More The money to AI stocks is a problem, and how it can be fixedApril 26, 2026 We do not have enough money coming into this market. The funds flow only to stocks tied to…
HHealthcare Read More 2 Healthcare Stocks at 52-Week Lows That Analysts Still LoveApril 21, 2026 Both Abbott Laboratories (ABT) and Boston Scientific (BSX) trade at or near 52-week lows while Wall Street analysts…
HHealthcare Read More Abbott closing Exact Sciences acquisition next week | NewsMarch 20, 2026 MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.…
IIreland Read More Abbott Ireland submit plans for further expansion in KilkennyJanuary 20, 2026 Abbott Ireland are seeking permission for an extension of their existing industrial building on site and alterations to…
PPersonal finance Read More Retirement is changing. Here’s why companies need to change, tooDecember 31, 2025 America’s workforce is on the verge of an unprecedented transformation. More Americans are turning 65 in 2025 than…
HHealthcare Read More Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue JumpDecember 10, 2025 24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…
MMarkets Read More Here are the 3 big things we’re watching in the stock market in this weekOctober 19, 2025 Last week started with the big banks delivering strong earnings and ended with regional lenders writing off bad…
MMarkets Read More Most US stocks rise after swinging through another erratic dayOctober 15, 2025 NEW YORK (AP) — Most U.S. stocks rose Wednesday following another topsy-turvy day on Wall Street. The S&P…